Ispanija - ispanų - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

boiron sociedad iberica de homeopatia s.a. - comprimido bucodispersable - en revisión - otros productos terapéuticos

Europos Sąjunga - ispanų - EMA (European Medicines Agency)

gilead sciences ireland uc - cobicistat - infecciones por vih - antivirales para uso sistémico - tybost is indicated as a pharmacokinetic enhancer of atazanavir 300 mg once daily or darunavir 800 mg once daily as part of antiretroviral combination therapy in human immunodeficiency virus-1 (hiv-1) infected adults and adolescents aged 12 years and older:weighing at least 35 kg co‑administered with atazanavir orweighing at least 40 kg co‑administered with darunavir.